155 related articles for article (PubMed ID: 36426138)
1. Cytomegalovirus-Specific T Cells from Third-Party Donors Successfully Treated Refractory Cytomegalovirus Retinitis after Unrelated Umbilical Cord Blood Transplantation.
Li N; Sun G; Zhu L; Ding K; Liu H; Zhu X; Tang B; Yao W; Wan X; Geng L; Qiang P; Song K; Zheng C; Sun Z; Tong J
J Immunol Res; 2022; 2022():6285510. PubMed ID: 36426138
[TBL] [Abstract][Full Text] [Related]
2. Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis after stem cell transplantation: effective monitoring of CMV infection by quantitative analysis of CMV mRNA.
Ohta H; Matsuda Y; Tokimasa S; Sawada A; Kim JY; Sashihara J; Amo K; Miyagawa H; Tanaka-Taya K; Yamamoto S; Tano Y; Aono T; Yamanishi K; Okada S; Hara J
Bone Marrow Transplant; 2001 Jun; 27(11):1141-5. PubMed ID: 11551024
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of risk factors and prognosis of cytomegalovirus infection post umbilical cord blood stem cell transplantation in children with primary immunodeficiency diseases].
Wei ZL; Qian XW; Wang P; Jiang WJ; Wang HS; Shen C; Wang WJ; Hou J; Wang YH; Huang Y; Wang XC; Zhai XW
Zhonghua Er Ke Za Zhi; 2022 Oct; 60(10):1019-1025. PubMed ID: 36207848
[No Abstract] [Full Text] [Related]
4. Donor CMV-specific cytotoxic T lymphocytes successfully treated drug-resistant cytomegalovirus encephalitis after allogeneic hematopoietic stem cell transplantation.
Ke P; Bao X; Zhou J; Li X; Zhuang J; He X; Wu D; Zhang X; Ma X
Hematology; 2020 Dec; 25(1):43-47. PubMed ID: 31906810
[No Abstract] [Full Text] [Related]
5. Cytomegalovirus retinitis after hematopoietic stem cell transplantation with alemtuzumab.
Song WK; Min YH; Kim YR; Lee SC
Ophthalmology; 2008 Oct; 115(10):1766-70. PubMed ID: 18562004
[TBL] [Abstract][Full Text] [Related]
6. Infections of the Central Nervous System after Unrelated Donor Umbilical Cord Blood Transplantation or Human Leukocyte Antigen-Matched Sibling Transplantation.
Balaguer Rosello A; Bataller L; Lorenzo I; Jarque I; Salavert M; González E; Piñana JL; Sevilla T; Montesinos P; Iacoboni G; Muelas N; Romero S; Carretero C; Montoro J; Ibáñez-Juliá MJ; Sanz G; Sanz MÁ; Sanz J
Biol Blood Marrow Transplant; 2017 Jan; 23(1):134-139. PubMed ID: 27794456
[TBL] [Abstract][Full Text] [Related]
7. Viral-specific T cells for Cytomegalovirus retinitis following hematopoietic stem cell transplantation: A success story.
Montiel-Esparza R; Michalak SM; Le AHD; Or C; Nguyen QD; Khoury R; Grimley MS; Bertaina A; Klinger E; Shah AJ; Wood EH
Pediatr Blood Cancer; 2023 Aug; 70(8):e30429. PubMed ID: 37243390
[TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus retinitis in children and adolescents with acute leukemia following allogeneic hematopoietic stem cell transplantation.
Zöllner SK; Herbrüggen H; Kolve H; Mihailovic N; Schubert F; Reicherts C; Rössig C; Groll AH
Transpl Infect Dis; 2019 Oct; 21(5):e13089. PubMed ID: 30972869
[TBL] [Abstract][Full Text] [Related]
9. Multiple intravitreal injections of ganciclovir for cytomegalovirus retinitis after stem-cell transplantation.
Miao H; Tao Y; Jiang YR; Li XX
Graefes Arch Clin Exp Ophthalmol; 2013 Jul; 251(7):1829-33. PubMed ID: 23665863
[TBL] [Abstract][Full Text] [Related]
10. Umbilical Cord Blood Cytomegalovirus Serostatus Does Not Have an Impact on Outcomes of Umbilical Cord Blood Transplantation for Acute Leukemia.
Nikolajeva O; Rocha V; Danby R; Ruggeri A; Volt F; Baudoux E; G Gomez S; Kögler G; Larghero J; Lecchi L; Martinez MS; Navarrete C; Pouthiers F; Querol S; Kenzey C; Szydlo R; Gluckman E; Madrigal A
Biol Blood Marrow Transplant; 2017 Oct; 23(10):1729-1735. PubMed ID: 28687394
[TBL] [Abstract][Full Text] [Related]
11. Cytomegalovirus infections in unrelated cord blood transplantation in pediatric patients: incidence, risk factors, and outcomes.
Al-Hajjar S; Al Seraihi A; Al Muhsen S; Ayas M; Al Jumaah S; Al Jefri A; Shoukri M; El Solh H
Hematol Oncol Stem Cell Ther; 2011; 4(2):67-72. PubMed ID: 21727767
[TBL] [Abstract][Full Text] [Related]
12. Case report: persistent cytomegalovirus (CMV) infection after haploidentical hematopoietic stem cell transplantation using in vivo alemtuzumab: emergence of resistant CMV due to mutations in the UL97 and UL54 genes.
Oshima K; Kanda Y; Kako S; Asano-Mori Y; Watanabe T; Motokura T; Chiba S; Shiraki K; Kurokawa M
J Med Virol; 2008 Oct; 80(10):1769-75. PubMed ID: 18712833
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic stem cell transplantation for children with β-thalassemia major: multicenter experience in China.
Li XY; Sun X; Chen J; Qin MQ; Luan Z; Zhu YP; Fang JP
World J Pediatr; 2018 Feb; 14(1):92-99. PubMed ID: 29511925
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of foscarnet for preemptive therapy against cytomegalovirus reactivation after unrelated cord blood transplantation.
Takami A; Mochizuki K; Ito S; Sugimori C; Yamashita T; Asakura H; Okumura H; Nakao S
Transplant Proc; 2007; 39(1):237-9. PubMed ID: 17275512
[TBL] [Abstract][Full Text] [Related]
15. Comparative outcomes between cord blood transplantation and bone marrow or peripheral blood stem cell transplantation from unrelated donors in patients with hematologic malignancies: a single-institute analysis.
Chen YH; Xu LP; Liu DH; Chen H; Zhang XH; Han W; Wang FR; Wang JZ; Wang Y; Huang XJ; Liu KY
Chin Med J (Engl); 2013 Jul; 126(13):2499-503. PubMed ID: 23823825
[TBL] [Abstract][Full Text] [Related]
16. Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT.
Neuenhahn M; Albrecht J; Odendahl M; Schlott F; Dössinger G; Schiemann M; Lakshmipathi S; Martin K; Bunjes D; Harsdorf S; Weissinger EM; Menzel H; Verbeek M; Uharek L; Kröger N; Wagner E; Kobbe G; Schroeder T; Schmitt M; Held G; Herr W; Germeroth L; Bonig H; Tonn T; Einsele H; Busch DH; Grigoleit GU
Leukemia; 2017 Oct; 31(10):2161-2171. PubMed ID: 28090089
[TBL] [Abstract][Full Text] [Related]
17. Incidence, risk factors, and outcome of cytomegalovirus infection and disease in patients receiving prophylaxis with oral valganciclovir or intravenous ganciclovir after umbilical cord blood transplantation.
Montesinos P; Sanz J; Cantero S; Lorenzo I; Martín G; Saavedra S; Palau J; Romero M; Montava A; Senent L; Martínez J; Jarque I; Salavert M; Córdoba J; Gómez L; Weiss S; Moscardó F; de la Rubia J; Larrea L; Sanz MA; Sanz GF
Biol Blood Marrow Transplant; 2009 Jun; 15(6):730-40. PubMed ID: 19450758
[TBL] [Abstract][Full Text] [Related]
18. Reconstitution of protective immune responses against cytomegalovirus and varicella zoster virus does not require disease development in pediatric recipients of umbilical cord blood transplantation.
Merindol N; Salem Fourati I; Brito RM; Grenier AJ; Charrier E; Cordeiro P; Caty M; Mezziani S; Malette B; Duval M; Alfieri C; Ovetchkine P; Le Deist F; Soudeyns H
J Immunol; 2012 Nov; 189(10):5016-28. PubMed ID: 23034171
[TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
[TBL] [Abstract][Full Text] [Related]
20. [Umbilical cord blood cell transplantation from an unrelated donor: dual transplantation].
Bautista G; Regidor C; Gonzalo-Daganzo R; Cabrera JR
Methods Find Exp Clin Pharmacol; 2010 Dec; 32 Suppl A():47-51. PubMed ID: 21381288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
